Effects of long-acting injectable risperidone on cognitive function in patients with schizophrenia

被引：0
|
作者：
Kim, S. W. [1 ]
Lee, Y. H. [2 ]
Lee, J. H. [3 ]
Chung, K. H. [2 ]
Yoo, J. A. [1 ]
Ryu, J. H. [4 ]
Yoon, J. S. [1 ]
Kim, J. M. [1 ]
Shin, I. S. [1 ]
Yang, S. J. [1 ]
机构：
[1] Chonnam Natl Univ Hosp, Dept Psychiat, Kwangju, South Korea
[2] St Johns Hosp, Dept Psychiat, Kwangju, South Korea
[3] Gwangju City Mental Hosp, Dept Psychiat, Kwangju, South Korea
[4] Yeosu Chonnam Hosp, Dept Psychiat, Kwangju, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词：
D O I：
10.1016/S0924-977X(09)70821-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S518 / S518
页数：1
相关论文
共 50 条
  • [31] Treatment compliance in veterans administration schizophrenia spectrum patients treated with risperidone long-acting injectable
    Duncan, Erica J.
    Woolson, Sandra L.
    Hamer, Robert M.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (05) : 283 - 290
  • [32] Extrapyramidal syndrome and long-acting injectable risperidone
    Hale, AS
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (04): : 756 - 757
  • [33] Long-acting injectable risperidone: Efficacy and safety
    Kane, JM
    Eerdekens, M
    Keith, SJ
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [34] Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable
    Fernanda Rosa
    Andreas Schreiner
    Pierre Thomas
    Tarek Sherif
    [J]. Clinical Drug Investigation, 2012, 32 : 267 - 279
  • [35] Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
    Hori, Hikaru
    Katsuki, Asuka
    Atake, Kiyokazu
    Yoshimura, Reiji
    [J]. FRONTIERS IN PSYCHIATRY, 2018, 9
  • [36] Comparison of Subjective Experiences and Effectiveness of First-Generation Long-Acting Injectable Antipsychotics and Risperidone Long-Acting Injectables in Patients With Schizophrenia
    Chen, Wen-Yin
    Lin, Shih-Ku
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (05) : 492 - 495
  • [37] Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
    Apostolos Aidonopoulos
    Anastasios Kanistras
    Anastasia Karastergiou
    Athanasios Karavatos
    Konstantinos Katsafouros
    Konstantinos Kontis
    Venetsanos Mavreas
    Maria Tzanakaki
    Nikolaos Tzavaras
    Errikos Tzebelikos
    [J]. Annals of General Psychiatry, 5 (Suppl 1)
  • [38] Two years follow up study with long-acting injectable risperidone in schizophrenia
    Chinchilla, A.
    Vega, M.
    Crespo, D.
    Yanez, R.
    Pando, F.
    Benitez, E.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 155 - 156
  • [39] Haloperidol decanoate and long-acting injectable risperidone: subjective experience of outpatients with schizophrenia
    Dalmotto, M.
    Pirfo, E.
    [J]. JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2010, 16 (03): : 299 - 304
  • [40] A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
    Li, Huafang
    Rui, Qing
    Ning, Xiaoping
    Xu, Haiyan
    Gu, Niufan
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (04): : 1002 - 1008
12345